Abstract

A flexible strategy to access to dialkyl (((N-(2-chloroethyl)-N-sulfamoyl) amino) arylmethyl) phosphonates, as sulfonamidophosphonates precursors of Fotemustine analogues was developed. The last nitrosation step proceeded as a rearrangement to the non expected sulfonate analogues.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call